Hopefully the data for poor responders comes shortly after
Related topics
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
| Newron Pharmaceuticals - Evenamide set for a pivotal year - Edison Investment | 0 | 127 | March 22, 2024 | |
| Newron announces approval for pivotal Phase III study of Evenamide | 4 | 90 | May 12, 2025 | |
| Newron and EA Pharma announce license agreement for evenamide in Japan and other Asian territories | 0 | 70 | January 30, 2025 | |
| Evenamide could be a potential breakthrough treatment in the management of treatment-resistant schizophrenia (TRS) patients | 2 | 420 | February 17, 2023 | |
| Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia | 5 | 671 | June 9, 2022 |